Arpelos Biosciences
Cambridge, United States · Founded 2021 · $9.5M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 1–10
- Founded
- 2021
- Business Model
- B2B
- Website
- arpelos.com
- Total Funding
- $9.5M
- Last Round
- $9.5M Seed
- Rounds
- 1
About
Develops multivalent biologic therapeutics to achieve high potency and selectivity for targeted disease treatments.
Summary
Arpelos Biosciences is a Biotech company based in Cambridge, United States, founded in 2021. It has raised $9.5M in total across 1 round.
Tech & App Stack
1 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Unknown
Similar Companies
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
Develops Gene Writing technology and non-viral delivery to create in vivo genetic medicines for m...
San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/arpelos-biosciences"><img src="https://indexed.vc/api/badge/company/arpelos-biosciences" alt="Arpelos Biosciences on Indexed.vc" width="260" height="76" /></a>